Angiotech (ANPI) FDA 501K Clearance 6/8/09

Angiotech Pharmaceuticals, Inc. (ANPI) is out with FDA Approval news this morning. ANPI stock is soaring to $2.75 in pre market trading!

Discuss Stocks - http://stockstobuy.org/ - Discuss ANPI

ANGIOTECH PHARMACEUTICALS ANNOUNCES FDA 510(K) CLEARANCE OF THE OPTION™ INFERIOR VENA CAVA FILTER

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, for use in both permanent and retrievable indications. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP (Rex Medical), as previously announced in March 2008.

The Option IVC Filter is used for the prevention of recurrent pulmonary embolism (PE). The device is implanted, typically by interventional radiologists in a minimally invasive procedure, into the body's inferior vena cava to prevent PE. Option is specifically designed for use as both a permanent or temporary implant (in temporary, or retrievable, indications, a physician may later perform a second surgical procedure to remove the Option IVC Filter if necessary or where mandated clinically).

http://www.angiotech.com/news/press-releases/pdf/2009/06-08-2009_OptionFDA_FINAL.pdf

For More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE